Banco Santander S.A. (BSD2)
XETRA Stock Exchange · Germany · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 11.50 |
|---|---|
| 52-week range | 8.31 – 13.10 |
| Return, 1 month / 3 months | −9.3% / −4.9% |
| Return, 1 year / 3 years | +40.7% / +269.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 36 |
| Volatility (1 year) | 30.3% |
| Worst drawdown (1 year) | -17.3% |
| Average daily value traded | 0.48M EUR |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Banco Santander is a banking group based in Spain that offers retail and commercial banking to individuals, households and businesses. Its services include current and savings accounts, mortgages, consumer loans, credit cards, business lending and investment products. The group serves customers through branch networks and digital channels in its home market and in other countries, and it also provides corporate and investment banking services to larger companies and institutional clients.
The shares are listed on the XETRA Stock Exchange in Germany under the code BSD2, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Banco Santander S.A. (BSD2) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 11.50 on 22 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a strong price profile), ranking 96 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 40.7% and over the last three months it fell 4.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 73 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 2.4% | ||
| From 52-week high | -11.5% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.9% | ||
| 6-month return | 10.4% | ||
| 12-month return, skipping the last month | 55.1% | ||
| Stability (higher is calmer) | 75 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.3% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.48M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −4.2% |
|---|---|
| 1 month | −9.3% |
| 3 months | −4.9% |
| 6 months | +10.4% |
| 1 year | +40.7% |
| 3 years | +269.5% |
| 5 years | +320.2% |
Signals
| 50-day / 200-day average | 12.45 / 11.23 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.29 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Apr 2026 | EUR 0.1250 |
| 30 Oct 2025 | EUR 0.1150 |
| 29 Apr 2025 | EUR 0.1100 |
| 30 Oct 2024 | EUR 0.1000 |
| 29 Apr 2024 | EUR 0.0950 |
| 31 Oct 2023 | EUR 0.0810 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.